Gingko
Ginkgo
银杏（Ginkgo biloba）是一种起源于东亚的传统药物，特别是中国和日本。根据历史记录，它没有被用于特定的医疗目的。前期研究显示银杏可能通过多种机制具有神经保护作用，但临床证据尚不足以支持其常规使用。最近的研究表明，如槲皮素和银杏生物碱B等成分可能会调节C3和C5补体蛋白，这可能对干性年龄相关性黄斑变性有益。技术进步提高了从银杏中提取活性化合物的能力。尚未记录到任何重大安全问题或药物相互作用；然而，需要进一步的临床试验来确认其在人类中的有效性和安全性。
- 最佳证据
- A
- 注意事项
- —
仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。
科学怎么说
- 前期研究提示银杏可能通过多种机制发挥神经保护作用，但临床数据不足以支持常规使用。
- 研究发现 GbMYB15 是 Ginkgo biloba 中总黄酮合成的负向调节因子。
- 研究显示，银杏叶提取物中的成分，尤其是槲皮素和银杏生物碱B，可能调节C3和C5补体蛋白，这可能对干性年龄相关性黄斑变性有益。
- 最近的技术创新改善了银杏提取物中生物活性化合物的提取和递送。
- 该研究确定了在银杏树（Ginkgo biloba）次生细胞壁发育过程中参与纤维素、半纤维素和木质素生物合成的关键基因。
- 研究发现，树龄是银杏叶中总双花色素含量的主要负调节因素。
- 研究将银杏叶识别为与GLP-1 RA减肥疗法中不良事件模式相关的顶级药用植物之一。
- 这项研究建议，各种植物提取物可能为心力衰竭提供治疗潜力，不同的提取物在改善心脏功能、生活质量及预后方面表现出优势。
- 研究确定了银杏乙种皮中银杏酸生物合成的关键基因和细胞机制。
- 研究发现，辅助手段GLED治疗与老年患者在PFNA手术后发生的亚急性深静脉血栓形成率显著降低相关，但仍需进一步研究。
Frequently asked questions
What is Gingko?
Gingko (Ginkgo) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Gingko?
10 sourced findings are recorded for Gingko; the strongest carries evidence grade A. For example: 前期研究提示银杏可能通过多种机制发挥神经保护作用，但临床数据不足以支持常规使用。
How strong is the evidence for Gingko?
The strongest finding for Gingko carries evidence grade A — strong evidence. Grades run A (strongest) to D (preliminary or traditional).
Is Gingko safe? What are the side effects?
No major safety issues are recorded for Gingko in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Gingko interact with medications?
No drug interactions are recorded for Gingko in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Gingko?
Gingko is also known as: Гинкго.
Is Gingko a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
来源
- T2 Advanced extraction to targeted delivery: A holistic review of technological innovations and therapeutic mechanisms of Ginkgo biloba extract. literature abstract metadata
- T2 Ginkgo biloba as a Promising Candidate for Traumatic Brain Injury: Insights From Preclinical and Clinical Studies. literature abstract metadata
- T2 Complement-Modulating Mechanisms of Ginkgo biloba Extract in Dry AMD: Insights From Molecular Docking and Dynamics Simulations. literature abstract metadata
- T2 Identification and functional analysis of GbMYB15 as a negative regulator in flavonoid biosynthesis of Ginkgo biloba. literature abstract metadata
- T2 The role of ginkgo leaf extract and dipyridamole adjuvant treatment for reduction of lower limb deep vein thrombosis after proximal femoral nail antirotation surgery in elderly patients with intertrochanteric femoral fracture. literature abstract metadata
- T2 Single-nucleus sequencing and spatial metabolomics analysis reveal the regulatory mechanism of ginkgolic acid biosynthesis in the episperm of Ginkgo biloba. literature abstract metadata
- T2 Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis. literature abstract metadata
- T2 Patterns of Biflavonoid Accumulation in Ginkgo (Ginkgo biloba L.) Leaves from 90 Trees and Their Variation with Age, Gender, and Location. literature abstract metadata
- T2 Revealing the genetic regulation of wood traits and secondary cell wall development in Ginkgo biloba: an integrated analysis from the perspectives of GWAS, TWAS, and WGCNA. literature abstract metadata
- T2 Real-world and computational identification of herbal candidates associated with adverse event patterns in glucagon-like peptide-1 therapy for obesity. literature abstract metadata